Navigation Links
Inovio Pharmaceuticals to Present at BIO CEO & Investor Conference
Date:2/4/2013

ons set forth herein as a result of a number of factors, including uncertainties inherent in pre-clinical studies, clinical trials and product development programs (including, but not limited to, the fact that pre-clinical and clinical results referenced in this release may not be indicative of results achievable in other trials or for other indications, that the studies or trials may not be successful or achieve the results desired, that pre-clinical studies and clinical trials may not commence or be completed in the time periods anticipated, that results from one study may not necessarily be reflected or supported by the results of other similar studies and that results from an animal study may not be indicative of results achievable in human studies), the availability of funding to support continuing research and studies in an effort to prove safety and efficacy of electroporation technology as a delivery mechanism or develop viable DNA vaccines, the adequacy of our capital resources, the availability or potential availability of alternative therapies or treatments for the conditions targeted by the company or its collaborators, including alternatives that may be more efficacious or cost-effective than any therapy or treatment that the company and its collaborators hope to develop, evaluation of potential opportunities, issues involving product liability, issues involving patents and whether they or licenses to them will provide the company with meaningful protection from others using the covered technologies, whether such proprietary rights are enforceable or defensible or infringe or allegedly infringe on rights of others or can withstand claims of invalidity and whether the company can finance or devote other significant resources that may be necessary to prosecute, protect or defend them, the level of corporate expenditures, assessments of the company's technology by potential corporate or other partners or collaborators, our ability to secure new partnership
'/>"/>
SOURCE Inovio Pharmaceuticals Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Inovios Synthetic Flu Vaccine Doubles Rate of Elderly Subjects Displaying Protective Immune Responses
2. Inovio Expands Synthetic Vaccine Intellectual Property License With University of Pennsylvania
3. Inovio Pharmaceuticals Reports 2012 Third Quarter Financial Results
4. Inovio Pharmaceuticals Takes Major Stride Toward Universal Influenza Vaccine
5. Inovio Pharmaceuticals Reports 2012 Second Quarter Financial Results
6. Inovio Pharmaceuticals Inc. Investor Presentation Now Available for On-demand Viewing at RetailInvestorConferences.com
7. Inovio Pharmaceuticals Inc. to Webcast, Live, at RetailInvestorConferences.com on August 2nd
8. Inovio Initiates H1N1 Universal Influenza Vaccine Clinical Trial Targeting Over-65 Population, Which Represents 90% of Flu Deaths
9. Inovio Pharmaceuticals to Present at JMP Investor Conference
10. Inovio Pharmaceuticals Universal Avian Flu Vaccine Generates Protective Antibody Responses Against Six H5N1 Viruses in Phase I Trial
11. Inovio Pharmaceuticals to Present at SPI 2012
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/22/2014)... Ill. , Sept. 22, 2014  AbbVie ... from several clinical studies evaluating potential new medicines ... at the upcoming 2014 European Society of Medical ... Madrid, Spain . Data being presented ... the safety and efficacy of veliparib (ABT-888), a ...
(Date:9/22/2014)... , Sept. 22, 2014  Seres Health, a ... to the human microbiome, today announced that it has ... 2014,s Fierce 15 biotechnology companies, designating it as one ... industry.  "Amid a great deal of ... its focus and commitment to practical therapeutic development," says ...
(Date:9/22/2014)... 22, 2014 Research and Markets  has ... Diclofenac Industry Report 2014" report to their offering. ... Report 2014 is a professional and in-depth study on ... a focus on the Chinese situation. The ... definitions, classifications, applications and industry chain structure. The diclofenac ...
Breaking Medicine Technology:AbbVie to Present Clinical Study Data on Potential New Oncology Medicines at the 2014 European Society of Medical Oncology Annual Meeting 2AbbVie to Present Clinical Study Data on Potential New Oncology Medicines at the 2014 European Society of Medical Oncology Annual Meeting 3AbbVie to Present Clinical Study Data on Potential New Oncology Medicines at the 2014 European Society of Medical Oncology Annual Meeting 4Seres Health Named a "Fierce 15" Biotech Company for 2014 2Global and Chinese Diclofenac Industry Report 2014 2
... 2011 BioMarin Pharmaceutical Inc. (Nasdaq: BMRN ) ... will present a company update at the Wedbush Life Sciences ... 10:00 a.m. ET. Interested parties may access a ... section of the BioMarin website, www.BMRN.com .  A replay ...
... 2011 Healthy Advice ® Networks, the ... engagement programs at point-of-care, announces that their partner, ... promote the Food and Drug Administration,s campaign, educating ... pain relievers. Partnering with MediaForce PR, Healthy ...
Cached Medicine Technology:BioMarin to Present at the Wedbush Life Sciences Conference 2Healthy Advice® Networks Partners With MediaForce PR to Deliver Public Service Announcements to Educate Consumers About Appropriate Use of Prescription Medications 2Healthy Advice® Networks Partners With MediaForce PR to Deliver Public Service Announcements to Educate Consumers About Appropriate Use of Prescription Medications 3
(Date:9/22/2014)... By Alan Mozes ... -- Pediatricians, take note: Many American parents are aware of ... to choose a pediatrician for their children, according to a ... from more than 1,600 parents -- further suggest that negative ... if that doctor has been recommended by a neighbor. ...
(Date:9/22/2014)... partner in the Global STEM Alliance, a new high-tech ... science, technology, engineering and math (STEM) around the world. ... (NYAS), Malaysian Prime Minister Najib Razak participated in the ... the goal of developing over 1,000,000 aspiring STEM leaders ... will create a host of learning opportunities, including student ...
(Date:9/22/2014)... 22, 2014 An inventor and anesthesiologist ... the problem of side-sleeping. "My lower arm always became ... designed a solution to this problem," she said. "It’s ... to have your arm 'fall asleep.'" , The Sleeping ... her side more comfortably. It avoids pain and restlessness ...
(Date:9/22/2014)... Quincy Bioscience, one of the fastest-growing ... National Self-Improvement Month this September. The Wisconsin-based ... access to self-improvement resources, especially for maintaining healthy ... products that preserve health is growing as Americans ... six years, Quincy Bioscience has been promoting the ...
(Date:9/22/2014)... The Workgroup for Electronic ... authority on the use of health IT to ... from its recent industry survey on the use ... electronic transactions adopted under the Health Insurance Portability ... from August 20 to September 5, which included ...
Breaking Medicine News(10 mins):Health News:Many Parents Use Online Ratings to Pick a Pediatrician, Study Finds 2Health News:Many Parents Use Online Ratings to Pick a Pediatrician, Study Finds 3Health News:Growing scientists: World's future jobs are rooted in STEM 2Health News:Growing scientists: World's future jobs are rooted in STEM 3Health News:Quincy Bioscience Promotes National Self-Improvement Month 2Health News:WEDI Announces Survey Results from Unique Health Plan Identifier (HPID) Industry Poll 2Health News:WEDI Announces Survey Results from Unique Health Plan Identifier (HPID) Industry Poll 3
... can be predicted with the use of diffusion-weighted MRI ... at New York University Medical Center in New York, ... chronic hepatitis in the United States, particularly hepatitis C, ... replace or supplement liver biopsy, which is relatively invasive ...
... Allscripts (Nasdaq: MDRX ),the leading provider of ... to improve healthcare, announced today that,it will report ... ended September,30, 2007 after the stock market closes ... Standard Time on the same day, Allscripts management ...
... Oct. 23 After five,successful years of steady ... today that it is celebrating five years of,continued ... sales growth,that indicates reaching 100,000 orders by the ... ), "Our ReBuilder for Diabetic Peripheral Neuropathy ...
... YORK, October 23 Answers.com(TM) (NASDAQ:,ANSW) ... interactive health education,videos from HealthiNation, a ... health content on Answers.com. (See example ... to consumers in categories such as ...
... more information, more, expertise and more options in their ... Oct. 23 As more than 7,000 leaders and,providers ... Meeting and Exposition,of the American Association of Homes and ... in Orlando, Florida, to explore the future of aging,services, ...
... between parents ... and teens, INDIANAPOLIS, ... at preventing drunk driving and,underage drinking with new 30-second radio public service ... timed to,coincide with the busy fall season and will air 2,300 times ...
Cached Medicine News:Health News:MRI predicts liver fibrosis, study says 2Health News:Allscripts to Announce Third Quarter 2007 Results on November 8th 2Health News:Allscripts to Announce Third Quarter 2007 Results on November 8th 3Health News:ReBuilder Medical Technologies, Inc. Celebrates Five Years and 50,000th Shipment 2Health News:ReBuilder Medical Technologies, Inc. Celebrates Five Years and 50,000th Shipment 3Health News:Answers.com Adds HealthiNation Video Content to Answer Engine(TM) 2Health News:'Will You Still Love Me, Will You Still Need Me, When I'm 84?' 2Health News:Indiana Attorney General Steve Carter Addresses Drunk Driving and Underage Drinking in New Radio Campaign 2
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
Medicine Products: